top of page

Steering Committee

Miguel Garcia (Technophage)

  • CEO of LxBio Pharmaceuticals and TechnoPhage

  • Board member at VectorB2B 

  • Professor at the Egas Moniz Instituto Universitário

  • PharmD, Faculty of Pharmacy, University of Lisbon

  • PhD, Faculty of Pharmacy, University of Lisbon

  • MBA, Catholic University of Portugal

Miguel-Garcia-2.jpeg

Jorge Brandão (LxBio)

Jorge Brandão.png
  • Board member at LxBio Pharmaceuticals

  • Board member at SEAPOWER - Associação para o desenvolvimento da economia do mar

  • Manager at IBV - Innovation Bioventures, Lda

  • PADIS - Gestão de Unidades de Saúde, AESE Business School

Rui Rodrigues (VectorB2B)

  • Board member at VectorB2B 

  • Board member at DÁVI

  • Founder of Lusomedicamenta (Recipharm)

  • Senior manager in multinational pharmaceutical companies (Janssen Pharmaceuticals)

  • PharmD, Faculty of Pharmacy, University of Lisbon

Rui Rodrigues_edited.jpg

João Gonçalves (FFUL)

João Gonçalves.jpg
  • Board member at VectorB2B

  • Coordinator of iMed - Research Institute for Medicines

  • Director of the Department of Pharmacy, Pharmacology and Health Technologies at the Faculty of Pharmacy, University of Lisbon

  • PharmD, Faculty of Pharmacy, University of Lisbon

  • PhD, Faculty of Pharmacy, University of Lisbon

Innovation. Dedication. Expertise.

This committee will assume the following functions in the mobilizing agenda:

​

  • Approve the program of activities prepared for the agenda;

​

  • Ensure the alignment of the activities objectives with those of the «Mobilizing Agenda for Business Innovation» and with the strategic objectives of each of the partner members;

​

  • Ensure compliance with the program's contractual obligations towards the Financing Entity;

​

  • Oversee project progress;

​

  • Approve and execute proposed amendment requests to the investment contract;

​

  • Guide actions to solve problems and responses to the risks involved arising from the project;

​

  • Promote the dissemination and sharing of results;

​

  • Analyse and approve the technical-scientific Progress Reports;

​

  • Report project performance to the financing entity.

bottom of page